Apimeds Pharmaceuticals US Inc

NYSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/30/2026

Company Profile

IndustryDrug Manufacturers - Specialty & Generic

SectorHealthcare

ExchangeNYSE

Market Capitalization3.97 mln

Float0.56 mln

Earnings Date11/12/2026

Business Description

Apimeds Pharmaceuticals US Inc. is a United Arab Emirates-based company focused on building and managing bitcoin holdings as a core part of its financial strategy. It operates under the ownership of Inscobee Inc.

Key Fundamentals

EPS-36.03

ROE-71.95

ROIC-22.02

ROA-64.23

Interest Cover-4.47

EBITDA, mln-53.82

EV / EBITDA-0.24

EV / EBIT-0.24

Quote Details

Last 3.01

Change -0.2 (-6.23%)

Open 3.11

Volume 20,055

Turnover 60,366

Average Volume 4,936,692

Financial Ratios

Leverage Ratio1.20

Current Ratio0.51

Price / Book0.04

Debt / Equity0.14

Financial Strength

Piotroski F-Score 2 / 9

Short Ratio0.01

Short % of Float9.06

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	4.15%	89 / 100
1 Month	-26.59%	4 / 100
2 Months	-52.15%	1 / 100
6 Months	-82.8%	1 / 100
1 Year	-83.09%	1 / 100